Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer

被引:62
作者
Mills, Christopher C. [1 ]
Kolb, E. A. [2 ]
Sampson, Valerie B. [2 ]
机构
[1] Univ Delaware, Newark, DE USA
[2] Nemours Alfred I duPont Hosp Children, Nemours Ctr Canc & Blood Disorders, Wilmington, DE USA
关键词
CHILDRENS ONCOLOGY GROUP; PHASE-I TRIAL; REFRACTORY SOLID TUMORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; DEPENDENT KINASE INHIBITOR; SMALL-MOLECULE INHIBITOR; ACUTE MYELOID-LEUKEMIA; PRECLINICAL TESTING PROGRAM; AURORA-KINASE; CDK4/6; INHIBITOR;
D O I
10.1158/0008-5472.CAN-17-2066
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
This review describes the pivotal roles of cell-cycle and checkpoint regulators and discusses development of specific cell-cycle inhibitors for therapeutic use for pediatric cancer. The mechanism of action as well as the safety and tolerability of drugs in pediatric patients, including compounds that target CDK4/CDK6 (palbociclib, ribociclib, and abemaciclib), aurora kinases (AT9283 and MLN8237), Wee1 kinase (MK-1775), KSP (ispinesib), and tubulin (taxanes, vinca alkaloids), are presented. The design of mechanism-based combinations that exploit the cross-talk of signals activated by cell-cycle arrest, as well as pediatric-focused drug development, are critical for the advancement of drugs for rare childhood diseases. (C) 2017 AACR.
引用
收藏
页码:6489 / 6498
页数:10
相关论文
共 84 条
[1]
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma [J].
Barton, Kelly L. ;
Misuraca, Katherine ;
Cordero, Francisco ;
Dobrikova, Elena ;
Min, Hooney D. ;
Gromeier, Matthias ;
Kirsch, David G. ;
Becher, Oren J. .
PLOS ONE, 2013, 8 (10)
[2]
Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors [J].
Bendris, Nawal ;
Lemmers, Benedicte ;
Blanchard, Jean Marie .
CELL CYCLE, 2015, 14 (12) :1786-1796
[3]
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours [J].
Blagden, S. P. ;
Molife, L. R. ;
Seebaran, A. ;
Payne, M. ;
Reid, A. H. M. ;
Protheroe, A. S. ;
Vasist, L. S. ;
Williams, D. D. ;
Bowen, C. ;
Kathman, S. J. ;
Hodge, J. P. ;
Dar, M. M. ;
de Bono, J. S. ;
Middleton, M. R. .
BRITISH JOURNAL OF CANCER, 2008, 98 (05) :894-899
[4]
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: A collaborative Pediatric Branch, National Cancer Institute and Children's Cancer Group trial [J].
Blaney, SM ;
Seibel, NL ;
OBrien, M ;
Reaman, GH ;
Berg, SL ;
Adamson, PC ;
Poplack, DG ;
Krailo, MD ;
Mosher, R ;
Balis, FM .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1538-1543
[5]
Myc and cell cycle control [J].
Bretones, Gabriel ;
Dolores Delgado, M. ;
Leon, Javier .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2015, 1849 (05) :506-516
[6]
Calvo E C, 2005, PHILADELPHIA
[7]
Treatment of Hodgkin Lymphoma: A 50-Year Perspective [J].
Canellos, George P. ;
Rosenberg, Saul A. ;
Friedberg, Jonathan W. ;
Lister, T. Andrew ;
DeVita, Vincent T. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03) :163-+
[8]
WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas [J].
Caretti, Viola ;
Hiddingh, Lotte ;
Lagerweij, Tonny ;
Schellen, Pepijn ;
Koken, Phil W. ;
Hulleman, Esther ;
van Vuurden, Dannis G. ;
Vandertop, W. Peter ;
Kaspers, Gertjan J. L. ;
Noske, David P. ;
Wurdinger, Thomas .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (02) :141-150
[9]
Initial Testing (Stage 1) of the Kinesin Spindle Protein Inhibitor Ispinesib by the Pediatric Preclinical Testing Program [J].
Carol, Hernan ;
Lock, Richard ;
Houghton, Peter J. ;
Morton, Christopher L. ;
Kolb, E. Anders ;
Gorlick, Richard ;
Reynolds, C. Patrick ;
Maris, John M. ;
Keir, Stephen T. ;
Billups, Catherine A. ;
Smith, Malcolm A. .
PEDIATRIC BLOOD & CANCER, 2009, 53 (07) :1255-1263
[10]
Hitting the brakes: targeting microtubule motors in cancer [J].
Chandrasekaran, Gayathri ;
Tatrai, Peter ;
Gergely, Fanni .
BRITISH JOURNAL OF CANCER, 2015, 113 (05) :693-698